Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11239-023-02857-z.pdf
Reference6 articles.
1. Ndrepepa G, Lahu S, Aytekin A et al (2022) One-year ischemic and bleeding events according to renal function in patients with Non-ST-Segment elevation Acute coronary syndromes treated with percutaneous coronary intervention and third-generation antiplatelet drugs. Am J Cardiol 176(10):15–23. https://doi.org/10.1016/j.amjcard.2022.04.040
2. Lahu S, Scalamogna M, Ndrepepa G et al (2022) Prior myocardial infarction and treatment effect of Ticagrelor Versus Prasugrel in patients with Acute Coronary Syndromes - a post-hoc analysis of the ISAR-REACT 5 Trial. J Am Heart Assoc 11(24):e027257. https://doi.org/10.1161/JAHA.122.027257
3. Lahu S, Presch A, Ndrepepa G et al (2022) Ticagrelor or Prasugrel in patients with Acute Coronary Syndrome and high bleeding risk. Circ Cardiovasc Interv 15(10):e012204. https://doi.org/10.1161/CIRCINTERVENTIONS.122.012204
4. Godtfredsen SJ, Kragholm KH, Leutscher P et al (2022) Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study. Eur Heart J Acute Cardiovasc Care 11(9):697–705. https://doi.org/10.1093/ehjacc/zuac095
5. Costa F, van Klaveren D, James S et al (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389(10073):1025–1034. https://doi.org/10.1016/S0140-6736(17)30397-5
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retrospective review of non-ST segment elevation acute coronary syndrome presenting to the emergency department of a major tertiary center in Saudi Arabia;Annals of Saudi Medicine;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3